Roivant Sciences emerged as a unicorn entity in drugs and pharmaceuticals industries that aims for developing innovative therapies for inflammatory and fibrotic diseases, advancing therapies for autoimmune diseases, and so on. Established by a well known business personality, Vivek Ramaswamy, his career took a significant turn when he founded Roivant Sciences in 2014. Roivant Sciences is a biopharmaceutical company known for its innovative approach to drug development. Vivek Ramaswamy recognized the potential for improving the efficiency of drug development by repurposing existing medications and molecules. This strategy not only reduced the risks and costs associated with drug discovery but also accelerated the development process. One of the key milestones in Ramaswamy's career was the creation of subsidiary companies under the Roivant umbrella. These subsidiaries, known as "Vants," were focused on specific therapeutic areas, such as neurology, dermatology, and women